• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Alfu-Kal XL
    / Perrigo

    Active Ingredient
    Alfuzosin (HCl) 10 mg

    Status in Israel

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft

    Prolonged-Release Tablets

    30 X 10 mg

    not in the basket chart 81501 9326

    Related information


    For benign prostatic hypertrophy – one tablet, once a day.
    For adjuvant treatment to catheter withdrawal in urinary retention resulting from benign prostatic hypertrophy – one tabler, once a day.
    Treatment is initiated on the day the catheter is inserted and stopped the day after removal of the catheter ( a total of 3-4 days).
    Alfu-Kal XL should be taken immediately after dinner, preferably before going to sleep.
    See prescribing information for full details.


    Treatment of certain functional symptoms of benign prostatic hypertrophy, particularly if surgery has to be delayed for some reason.


    Hypersensitivity. Orthostatic hypotension, impaired hepatic function, severe renal insufficiency.

    Special Precautions

    In some subjects, particularly those treated with antihypertensive medication, orthostatic hypotension may develop after taking the drug, possibly accompanied by symptoms (dizziness, fatigue, sweating). Caution is recommended, particularly in the elderly. These effects are usually transient, occur at the beginning of treatment and do not usually prevent the continuation of treatment. The patient must be informed of the possible occurrence of such incidents. In coronary patients, alfuzosin should not be prescribed alone. Specific medication for coronary insufficiency should be continued. In the event of the recurrence or exacerbation of angina, treatment with alfuzosin should be stopped. Treatment should be initiated gradually in patients with hypersensitivity to alpha-1 blockers. Should be administered carefully to patients being treated with antihypertensives. Blood pressure should be monitored regularly, especially at the beginning of the treatment. Particular caution is required when driving vehicles or using machines due to the risks of orthostatic hypotension, especially at the start of treatment.

    Side Effects

    GI disturbances: Nausea, gastric pain, diarrhea. Light-headedness, dizziness, feeling faint. Headaches.

    Drug interactions

    Antihypertensive alpha-blockers (prazosin, urapidil, minoxidil). Antihypertensive drugs. General anaesthetics: It is recommended that alfuzosin be withdrawn 24 hours before surgery.

    Rivopharm SA